PPT-Evaluation and Management of Fabry Disease

Author : madeline | Published Date : 2024-02-09

Supported by Sanofi Genzyme Agenda Pathogenesis of Fabry Disease Evaluation of Fabry Disease Fabry Disease Management Learning Objectives Discuss the pathophysiology

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Evaluation and Management of Fabry Disea..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Evaluation and Management of Fabry Disease: Transcript


Supported by Sanofi Genzyme Agenda Pathogenesis of Fabry Disease Evaluation of Fabry Disease Fabry Disease Management Learning Objectives Discuss the pathophysiology of Fabry disease and its impact on kidney function to increase awareness. . Spectrographs. Measurements . of the line shift.. a(. sin. a. sin. b. ). g. rating constant. Echelle. spectrometer. The first . standard grating . is optimized for a single lower . order. The . echelle. Eric Barela, Ph.D.. Chief Organizational Performance Officer. Partners in School Innovation. 2010 American Evaluation Association Conference, . San Antonio, TX. Presentation roadmap. Organizational context. Learning objectives. By the end of this presentation, you will be able to:. Explain evaluation design . Describe . the differences between types of evaluation . designs. Identify . the key . elements . Deanna Bell, M.D., F.A.A.P.. Medical Director, MHIP. Tennessee Chapter of the American Academy of Pediatrics. Goals of D70 Grant. “ . . . to improve medical home provision for children and youth with special healthcare needs by promoting systems and service integration for children through education of parents and providers on medial home concepts of team-based care, care coordination, and disease management.”. Laying the Groundwork Before Your First Evaluation Diana Epstein, Ph.D, CNCS Office of Research and Evaluation Adrienne DiTommaso, MPA, CNCS Office of Research and Evaluation Learning objectives Understand five critical activities for your first grant cycle A . raremark. 2017. július 7-én megjelent „Fabry . disease. : . treatment. and management” cikke alapján. https://raremark.com/fabry-disease/articles/fabry-disease-treatment-and-management--579. Maryam. . Banikazemi. , MD. Associate Prof of Pediatric and Genetics. New York Medical College . & . Shahid. . Beheshti. University. Overview of clinical & Diagnostic Approaches to Inherited Metabolic Disorders. Lodovico Balducci M.D.. Senior Member Emeritus. Moffitt Cancer Center. Tampa, FL. Clinical Case. 83 year old man with cough. CT chest reveals a 3 cm mass Left Lower Lobe. Biopsy reveals an adenocarcinoma primary lung. Storage Diseases. Michael . H. Gelb (. Dept. . of . Chemistry & Biochemistry, . Univ. of Washington. ). 30 . yrs. of experience in enzymology, organic chemistry, mass spec.. Frank . Turecek. (Dept. of Chemistry, Univ. of Washington. www.hivguidelines.org. Purpose of the Guideline. Provide guidance on the management of HIV-associated periodontal lesions, which involves treating both bacteria and fungi. . Key Point:. . Chronic nonhealing lesions may indicate a more serious condition, and oral health care providers can use biopsies to identify any neoplastic changes.. IntroductionFabry disease (FD) arises from an X-linked defect in lipid storage, whereby deicient or -galactosidase A (-gal A) activity leads to systemic deposition of glyco-sphingolipids, mainly Page 64 of 69 FMNry diseMse: ProPoPype of IysosomMl SPorMge Gisorder RiPO sysPemic Hrene SMn-Román-MonserrMP*, JuMn-RMmón Gimeno-BlMnes Article InfoArticle Notes Fabry disease is a rare inherited m • What is Fabry Disease?• What Causes Fabry?• How Common is Fabry? Guide to Understanding Fabry Disease mps@mpssociety.or.ukwww.mpssociety.or.uk Dianosis of Fabry DiseaseFabry Dis Part I:Real World Evaluation Approaches . May 16, 2012 . YALE-GRIFFIN PREVENTION RESEARCH CENTER. David L. Katz, MD, MPH. Valentine Yanchou Njike, MD, MPH. Jesse Reynolds, MS. Engage stakeholders . Describe the program .

Download Document

Here is the link to download the presentation.
"Evaluation and Management of Fabry Disease"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents